Stocksigma LogoStocksigma Logo

NCLT Approves Bajaj Healthcare’s Acquisition of Genrx Pharmaceuticals

The Hon’ble NCLT, Mumbai Bench, approved Bajaj Healthcare Limited's acquisition of Genrx Pharmaceuticals Private Limited (in Liquidation) on a going

NCLT Approves Bajaj Healthcare’s Acquisition of Genrx Pharmaceuticals

Bajaj Healthcare Ltd · Others (Uncategorized) · 14 Oct 2026, 9:52 pm

NCLT Approves Bajaj Healthcare’s Acquisition of Genrx Pharmaceuticals The Hon’ble NCLT, Mumbai Bench, approved Bajaj Healthcare Limited's acquisition of Genrx Pharmaceuticals Private Limited (in Liquidation) on a going concern basis via an order dated 13th Oct'26. The approval follows the company's prior disclosures in Apr'25. Post-implementation of the terms specified in the NCLT order, Genrx Pharmaceuticals will become a wholly owned subsidiary of Bajaj Healthcare. The order became effective immediately on 13th Oct'26, and the company will initiate necessary actions to execute the acquisition in compliance with the NCLT directive.

Original exchange filing (PDF)

More announcements from Bajaj Healthcare Ltd

All Bajaj Healthcare Ltd announcements